Incidence of 30-Day Venous Thromboembolism in Adults Tested for SARS-CoV-2 Infection in an Integrated Health Care System in Northern California

doi:10.1001/jamainternmed.2021.0488

. 2021 Jul 1;181(7):997-1000.

doi: 10.1001/jamainternmed.2021.0488.

Incidence of 30-Day Venous Thromboembolism in Adults Tested for SARS-CoV-2 Infection in an Integrated Health Care System in Northern California

Nareg H Roubinian^{1

2

3}, Jennifer R Dusendang¹, Dustin G Mark^{1

2}, David R Vinson^{1

2}, Vincent X Liu^{1

2}, Julie A Schmittdiel¹, Ashok P Pai²

Affiliations

¹ Division of Research, Kaiser Permanente Northern California, Oakland.
² The Permanente Medical Group, Kaiser Permanente Northern California.
³ Vitalant Research Institute, San Francisco, California.

PMID: 33818615
PMCID: PMC8022258
DOI: 10.1001/jamainternmed.2021.0488

Incidence of 30-Day Venous Thromboembolism in Adults Tested for SARS-CoV-2 Infection in an Integrated Health Care System in Northern California

Nareg H Roubinian et al. JAMA Intern Med. 2021.

. 2021 Jul 1;181(7):997-1000.

doi: 10.1001/jamainternmed.2021.0488.

Authors

Nareg H Roubinian^{1

2

3}, Jennifer R Dusendang¹, Dustin G Mark^{1

2}, David R Vinson^{1

2}, Vincent X Liu^{1

2}, Julie A Schmittdiel¹, Ashok P Pai²

Affiliations

¹ Division of Research, Kaiser Permanente Northern California, Oakland.
² The Permanente Medical Group, Kaiser Permanente Northern California.
³ Vitalant Research Institute, San Francisco, California.

PMID: 33818615
PMCID: PMC8022258
DOI: 10.1001/jamainternmed.2021.0488

Erratum in

Error in Email Address.
[No authors listed] [No authors listed] JAMA Intern Med. 2021 Dec 1;181(12):1679. doi: 10.1001/jamainternmed.2021.6248. JAMA Intern Med. 2021. PMID: 34661598 Free PMC article. No abstract available.

Abstract

This cohort study examines the 30-day incidence of outpatient and hospital-associated venous thromboembolism following SARS-CoV-2 testing among adults in a large health system.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: Dr Roubinian reported grants from the National Institutes of Health and the National Heart, Lung, and Blood Institute (R01HL126130) during the conduct of the study. Dr Liu reported grants from the National Institute of General Medical Sciences (R35GM128672) during the conduct of the study. No other disclosures were reported.

Comment in

Risk of venous thromboembolism in COVID-19 infection.
Honkanen M, Sirkeoja S, Viskari H, Kailankangas V, Sinisalo M, Syrjänen J. Honkanen M, et al. Intern Med J. 2023 Aug;53(8):1478-1480. doi: 10.1111/imj.16145. Epub 2023 Jul 14. Intern Med J. 2023. PMID: 37449583

Cited by

Estimating the Effect of Coronavirus Disease 2019 (COVID-19) Vaccination and Infection Variant on Post-COVID-19 Venous Thrombosis or Embolism Risk.
O'Carroll A, Richard SA, Byrne C, Rusiecki J, Wier B, Berjohn CM, Fries AC, Lalani T, Smith AG, Mody RM, Ganesan A, Huprikar N, Colombo RE, Schofield C, Lindholm DA, Mende K, Jones MU, Flanagan R, Larson DT, Ewers EC, Saunders D, Maves RC, Maldonado CJ, Sanchez Edwards M, O'Connell RJ, Simons MP, Tribble DR, Agan BK, Burgess TH, Pollett SD. O'Carroll A, et al. Open Forum Infect Dis. 2024 Sep 23;11(11):ofae557. doi: 10.1093/ofid/ofae557. eCollection 2024 Nov. Open Forum Infect Dis. 2024. PMID: 39494453 Free PMC article.
Symptomatic Venous Thromboembolic Events in COVID-19 Patients after Hospital Discharge: Aspects to Consider.
Pop C, Hermenean A, Moș L, Cotoraci C. Pop C, et al. Rev Cardiovasc Med. 2022 Jun 20;23(6):219. doi: 10.31083/j.rcm2306219. eCollection 2022 Jun. Rev Cardiovasc Med. 2022. PMID: 39077187 Free PMC article. Review.
Thrombotic Long-Term Consequences of SARS-CoV-2 Infection in Patients with Compensated Cirrhosis: A Propensity Score-Matched Analysis of a U.S. Database.
Ayoub M, Faris C, Juranovic T, Aibani R, Koontz M, Chela H, Anwar N, Daglilar E. Ayoub M, et al. Diseases. 2024 Jul 17;12(7):161. doi: 10.3390/diseases12070161. Diseases. 2024. PMID: 39057132 Free PMC article.
Multidisciplinary Management Strategies for Long COVID: A Narrative Review.
Prusinski C, Yan D, Klasova J, McVeigh KH, Shah SZ, Fermo OP, Kubrova E, Farr EM, Williams LC, Gerardo-Manrique G, Bergquist TF, Pham SM, Engelberg-Cook E, Hare JM, March KL, Caplan AI, Qu W. Prusinski C, et al. Cureus. 2024 May 1;16(5):e59478. doi: 10.7759/cureus.59478. eCollection 2024 May. Cureus. 2024. PMID: 38826995 Free PMC article. Review.
Assessment of the Risk of Venous Thromboembolism in Nonhospitalized Patients With COVID-19.
Fang MC, Reynolds K, Tabada GH, Prasad PA, Sung SH, Parks AL, Garcia E, Portugal C, Fan D, Pai AP, Go AS. Fang MC, et al. JAMA Netw Open. 2023 Mar 1;6(3):e232338. doi: 10.1001/jamanetworkopen.2023.2338. JAMA Netw Open. 2023. PMID: 36912838 Free PMC article.

See all "Cited by" articles

References

1. Bilaloglu S, Aphinyanaphongs Y, Jones S, Iturrate E, Hochman J, Berger JS. Thrombosis in hospitalized patients with COVID-19 in a New York City health system. JAMA. 2020;324(8):799-801. doi:10.1001/jama.2020.13372 - DOI - PMC - PubMed
1. Packard A, Delate T, Martinez K, Clark NP. Adherence to and persistence with direct oral anticoagulant therapy among patients with new onset venous thromboembolism receiving extended anticoagulant therapy and followed by a centralized anticoagulation service. Thromb Res. 2020;193:40-44. doi:10.1016/j.thromres.2020.05.036 - DOI - PubMed
1. Spyropoulos AC, Ageno W, Albers GW, et al. ; MARINER Investigators . Rivaroxaban for thromboprophylaxis after hospitalization for medical illness. N Engl J Med. 2018;379(12):1118-1127. doi:10.1056/NEJMoa1805090 - DOI - PubMed
1. Roberts LN, Whyte MB, Georgiou L, et al. . Postdischarge venous thromboembolism following hospital admission with COVID-19. Blood. 2020;136(11):1347-1350. doi:10.1182/blood.2020008086 - DOI - PMC - PubMed
1. Moores LK, Tritschler T, Brosnahan S, et al. . Prevention, diagnosis, and treatment of VTE in patients with coronavirus disease 2019: CHEST guideline and expert panel report. Chest. 2020;158(3):1143-1163. doi:10.1016/j.chest.2020.05.559 - DOI - PMC - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Grants and funding

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information
Miscellaneous
- NCI CPTAC Assay Portal

[1] Bilaloglu S, Aphinyanaphongs Y, Jones S, Iturrate E, Hochman J, Berger JS. Thrombosis in hospitalized patients with COVID-19 in a New York City health system. JAMA. 2020;324(8):799-801. doi:10.1001/jama.2020.13372 - DOI - PMC - PubMed

[2] Bilaloglu S, Aphinyanaphongs Y, Jones S, Iturrate E, Hochman J, Berger JS. Thrombosis in hospitalized patients with COVID-19 in a New York City health system. JAMA. 2020;324(8):799-801. doi:10.1001/jama.2020.13372 - DOI - PMC - PubMed

[3] Packard A, Delate T, Martinez K, Clark NP. Adherence to and persistence with direct oral anticoagulant therapy among patients with new onset venous thromboembolism receiving extended anticoagulant therapy and followed by a centralized anticoagulation service. Thromb Res. 2020;193:40-44. doi:10.1016/j.thromres.2020.05.036 - DOI - PubMed

[4] Packard A, Delate T, Martinez K, Clark NP. Adherence to and persistence with direct oral anticoagulant therapy among patients with new onset venous thromboembolism receiving extended anticoagulant therapy and followed by a centralized anticoagulation service. Thromb Res. 2020;193:40-44. doi:10.1016/j.thromres.2020.05.036 - DOI - PubMed

[5] Spyropoulos AC, Ageno W, Albers GW, et al. ; MARINER Investigators . Rivaroxaban for thromboprophylaxis after hospitalization for medical illness. N Engl J Med. 2018;379(12):1118-1127. doi:10.1056/NEJMoa1805090 - DOI - PubMed

[6] Spyropoulos AC, Ageno W, Albers GW, et al. ; MARINER Investigators . Rivaroxaban for thromboprophylaxis after hospitalization for medical illness. N Engl J Med. 2018;379(12):1118-1127. doi:10.1056/NEJMoa1805090 - DOI - PubMed

[7] Roberts LN, Whyte MB, Georgiou L, et al. . Postdischarge venous thromboembolism following hospital admission with COVID-19. Blood. 2020;136(11):1347-1350. doi:10.1182/blood.2020008086 - DOI - PMC - PubMed

[8] Roberts LN, Whyte MB, Georgiou L, et al. . Postdischarge venous thromboembolism following hospital admission with COVID-19. Blood. 2020;136(11):1347-1350. doi:10.1182/blood.2020008086 - DOI - PMC - PubMed

[9] Moores LK, Tritschler T, Brosnahan S, et al. . Prevention, diagnosis, and treatment of VTE in patients with coronavirus disease 2019: CHEST guideline and expert panel report. Chest. 2020;158(3):1143-1163. doi:10.1016/j.chest.2020.05.559 - DOI - PMC - PubMed

[10] Moores LK, Tritschler T, Brosnahan S, et al. . Prevention, diagnosis, and treatment of VTE in patients with coronavirus disease 2019: CHEST guideline and expert panel report. Chest. 2020;158(3):1143-1163. doi:10.1016/j.chest.2020.05.559 - DOI - PMC - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Incidence of 30-Day Venous Thromboembolism in Adults Tested for SARS-CoV-2 Infection in an Integrated Health Care System in Northern California

Affiliations

Incidence of 30-Day Venous Thromboembolism in Adults Tested for SARS-CoV-2 Infection in an Integrated Health Care System in Northern California

Authors

Affiliations

Erratum in

Abstract

Conflict of interest statement

Comment in

Similar articles

Cited by

References

Publication types

MeSH terms

Grants and funding

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Miscellaneous

Erratum in

Abstract

Conflict of interest statement

Comment in

Similar articles

Cited by

References

Publication types

MeSH terms

Related information

Grants and funding

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Miscellaneous